Skip to content

Insider · CIK 0001185829

Kevin Koch

ceopresidentofficerdirector

Files at EWTX (Edgewise Therapeutics, Inc.). First filing Feb 7, 2025, latest Aug 14, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $467k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

EWTX: Edgewise Therapeutics, Inc.

EWTXOct 9, 2026 · close 39.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
EWTXsell 6
Edgewise Therapeutics, Inc.
$107k
7,972 shares
-21%+17% from low-63% from high
38Weak
EWTXsell 6
Edgewise Therapeutics, Inc.
$70k
4,276 shares
-17%+48% from low-54% from high
0Weak
EWTXsell 210b5-1
Edgewise Therapeutics, Inc.
$3,000
100 shares
-1%-
29Weak
EWTXsell 410b5-1
Edgewise Therapeutics, Inc.
$287k
9,536 shares
-41%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+17,968$0.00$038,587Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock
-7,972$13.39$107k30,615Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-17,968$0.00$053,907Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+87,500$0.00$087,500Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+525,000$0.00$0525,000Aug 14, 2025
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+10,417$0.00$024,895May 7, 2025
May 2, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock
-4,276$16.45$70k20,619May 7, 2025
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-10,417$0.00$00May 7, 2025
Mar 7, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+100$0.18$1814,578Mar 11, 2025
Mar 7, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-100$30.00$3,00014,478Mar 11, 2025
Mar 7, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-100$0.00$041,545Mar 11, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+8,636$0.18$1,55423,114Feb 7, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-8,636$30.03$259k14,478Feb 7, 2025
Feb 6, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+900$13.11$12k15,378Feb 7, 2025
Feb 6, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-900$31.13$28k14,478Feb 7, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-8,636$0.00$042,545Feb 7, 2025
Feb 6, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-900$0.00$041,645Feb 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin Koch: insider trades and track record | InsiderTell